New dementia prevention & care report: Two Univ. of Michigan experts available to comment
Michigan Medicine - University of Michigan
New research from the University of Washington shows Elon Musk’s projection for the latest Neuralink project rests on the flawed premise that implanting millions of tiny electrodes into the visual cortex, the region of the brain that processes information received from the eye, will result in high-resolution vision.
The American Society of Retina Specialists is honoring Richard B. Rosen, MD, ScD (hon), FACS, FASRS, FARVO, CRA, the Belinda Bingham Pierce and Gerald G. Pierce Distinguished Professor of Ophthalmology at the Icahn School of Medicine at Mount Sinai, with the prestigious Founders Award for 2024.
Today the American Academy of Ophthalmology announced the appointment of Sarah DeParis, MD, as Director of Quality and Clinical Standards under the Quality and Data Science Division.
Johns Hopkins Researchers Develop AI-Enhanced Navigation System for Visually Impaired
Mount Sinai study suggests adhering to FDA-regulated expiration dates could prevent this
A new study suggests patients taking semaglutide — the active ingredient in Ozempic and Wegovy — may be at higher risk of developing an eye condition that can cause blindness.
There’s only one U.S. Food and Drug Administration-approved therapy for an inherited retinal disease, and dozens of retinitis pigmentosa (RP) genes for which no therapy is available.
Printing a new cornea during an operation to restore a patient’s eyesight: This groundbreaking step in the fight against corneal disorders is set to become reality with a laser based process using personalized bioink. The method was developed by researchers at the Karlsruhe Institute of Technology (KIT) in collaboration with Carl Zeiss Meditec AG and Evonik Healthcare.
Scientists at the National Institutes of Health (NIH) have uncovered a brain circuit in primates that rapidly detects faces. The findings help not only explain how primates sense and recognize faces, but could also have implications for understanding conditions such as autism, where face detection and recognition are often impaired from early childhood.
A new study in mice hints at the promise of an eventual alternative treatment option for the “wet” version of age-related macular degeneration (AMD).
The Foundation Fighting Blindness, the driving force in the global development of treatments and cures for blinding diseases, announced today the appointment of Karen Petrou as Board Chair, effective July 1, 2024. Petrou succeeds David Brint, who is retiring after eight years of dedicated service.
Ahead of Independence Day on July 4, Virginia Tech experts can speak on a variety of topics, including fireworks safety, economic lessons from eating contests, grilling safety tips, and more. To schedule an interview, please contact the media relations office at [email protected]. Fireworks safety The July 4th holiday brings a dramatic increase in eye injuries each year.
A specialist with Bascom Palmer Eye Institute explains the importance of tears for both physical and emotional health.
TGF has expanded its Grant-in-Aid Program, broadening its focus and increasing funding. Three new grants have just been funded under the new guidelines.
Indiana University School of Medicine’s Yoshikazu Imanishi, PhD, was recently awarded a four-year, $2.1 million grant from the National Eye Institute and a three-year, $500,000 grant from the Foundation Fighting Blindness to study genetic causes of blindness.
Washington University School of Medicine in St. Louis led a clinical trial that tests the safety and efficacy of an FDA-approved drug in stabilizing vision in patients with RVCL-S, a rare genetic disease that affects tiny blood vessels in the body.
The discovery of how intricate networks of blood vessels in the eye and brain are formed could inspire new treatments for glaucoma, diabetic retinopathy, and stroke.
Increasing the levels of a key protein in the cells at the back of the eye could help protect against the leading cause of vision loss among older adults, finds a new discovery made by researchers from the UK, US, Germany and Australia.